This contract expires in 333 days (Sep 25, 2027).

Browse related active opportunities

NO SET ASIDE USED.

QIAGEN, LLC - EVIDENCE-BASED BIOINFORMATIC INTERPRETATION OF NEW GENERATION SEQUENCING DATA FOR PRECISION CANCER DIAGNOSTICS

PIID: 75N91024P00557Solicitation ID: 75N91024NOI6913951
Signed Date: Sep 25, 2024Effective Date: Sep 26, 2024End Date: Closes in 333 days
Award $
$479K
Vendor
QIAGEN, LLC
NAICS
541990
Signed Date
Sep 25, 2024

Key Details

Dollars Obligated
$478,500
Base & All Options
$945,938
Awarding Sub-Agency
National Institutes of Health
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
NOT COMPETED
Number of Offers
1
Place of Performance
GERMANTOWN, MD

Description

EVIDENCE-BASED BIOINFORMATIC INTERPRETATION OF NEW GENERATION SEQUENCING DATA FOR PRECISION CANCER DIAGNOSTICS

Context & Analysis

On Sep 25, 2024, Department of Health and Human Services obligated $478,500 to QIAGEN, LLC for evidence-based bioinformatic interpretation of new generation sequencing data for precision cancer diagnostics. The award is classified under NAICS 541990 — ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in GERMANTOWN, MD. The contract is scheduled through Sep 25, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541990 — related awards are listed below.

Contractor Information

Contractor: QIAGEN, LLC
UEI: W2GLKC92ZH73
Location: GERMANTOWN, MD
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related